Don Casey, Veteran Healthcare Exec, Joins Bonaventure Equity's Board Pioneering Cannabinoid and Psychedelic Medicine.

7 months ago 143

Bonaventure Equity, LLC

Don Casey, Veteran Healthcare Exec, Joins Bonaventure Equity's Board of Advisors in Pioneering Neuroscience, Cannabinoid & Psychedelic Medicine.

Don's exceptional track record in healthcare leadership plays a crucial role in helping us fulfill our mission of bringing innovative healthcare solutions to the patients who need it the most.”

— Ross O'Brien

RALEIGH, NORTH CAROLINA, USA, October 13, 2023 /EINPresswire.com/ -- Bonaventure Equity (“BVE”), a pioneering force in the world of healthcare and pharmaceutical venture capital, is thrilled to announce the addition of Don Casey to their Board of Advisors. Casey brings a wealth of health care experience that has included roles as a former Johnson & Johnson Executive Committee Member and multiple CEO and board positions of multiple health care companies. He will provide valuable perspective and strategic insight to BVE as the company bridges funding gaps in cannabinoid and psychedelic medicinal and clinical research, ushering in a new era of innovative treatments to tackle healthcare’s biggest challenges.

BVE invests in early-stage cannabinoid and psychedelic startups built on new scientific discoveries in neuroscience and patient care for diseases ranging from Alzheimer’s, fibromyalgia, PTSD, depression, stroke, and addiction, to name a few. With a distinguished career spanning decades in the pharmaceutical and healthcare industries, Casey's appointment as a key advisor to BVE represents a pivotal moment in the company's mission to advance groundbreaking research and therapies. His extensive background in venture capital, leadership roles, and his commitment to the betterment of human health align perfectly with BVE’s vision.

“Don Casey’s longstanding commitment to excellence and leadership extends beyond healthcare,” said Derrick Mayes, Managing Partner at BVE. “As a fellow Notre Dame alum (‘82 Swim) and Monogr...

Read Entire Article